Cardiovascular safety of etoricoxib
Meticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested alo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/371 |
| id |
doaj-22d1b86554c440a1883f9a7af199f127 |
|---|---|
| record_format |
Article |
| spelling |
doaj-22d1b86554c440a1883f9a7af199f1272021-07-29T09:00:07ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2011-09-0153525710.14412/1996-7012-2011-6861676Cardiovascular safety of etoricoxibViktoriya Georgievna BarskovaViktoria Georgiyevna BarskovaMeticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested along with other most studied medications from this group, by applying one of the latest meta-analyses. The EULAR recommendations to use NSAIDs are given.https://mrj.ima-press.net/mrj/article/view/371nonsteroidal anti-inflammatory drugscardiovascular safetyetoricoxib |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
Viktoriya Georgievna Barskova Viktoria Georgiyevna Barskova |
| spellingShingle |
Viktoriya Georgievna Barskova Viktoria Georgiyevna Barskova Cardiovascular safety of etoricoxib Современная ревматология nonsteroidal anti-inflammatory drugs cardiovascular safety etoricoxib |
| author_facet |
Viktoriya Georgievna Barskova Viktoria Georgiyevna Barskova |
| author_sort |
Viktoriya Georgievna Barskova |
| title |
Cardiovascular safety of etoricoxib |
| title_short |
Cardiovascular safety of etoricoxib |
| title_full |
Cardiovascular safety of etoricoxib |
| title_fullStr |
Cardiovascular safety of etoricoxib |
| title_full_unstemmed |
Cardiovascular safety of etoricoxib |
| title_sort |
cardiovascular safety of etoricoxib |
| publisher |
IMA-PRESS LLC |
| series |
Современная ревматология |
| issn |
1996-7012 2310-158X |
| publishDate |
2011-09-01 |
| description |
Meticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested along with other most studied medications from this group, by applying one of the latest meta-analyses. The EULAR recommendations to use NSAIDs are given. |
| topic |
nonsteroidal anti-inflammatory drugs cardiovascular safety etoricoxib |
| url |
https://mrj.ima-press.net/mrj/article/view/371 |
| work_keys_str_mv |
AT viktoriyageorgievnabarskova cardiovascularsafetyofetoricoxib AT viktoriageorgiyevnabarskova cardiovascularsafetyofetoricoxib |
| _version_ |
1721250389618065408 |